See every side of every news story
Published loading...Updated

Using Cancer Drugs for Alzheimer’s Disease — and More Health Headlines

SAN FRANCISCO, CALIFORNIA, JUL 21 – Two FDA-approved cancer drugs improved memory and reduced brain damage in Alzheimer's mice, with patient data showing up to 80% lower Alzheimer’s risk, researchers said.

  • On July 21, 2025, researchers at UCSF and Gladstone Institutes published findings showing memory improvements and reduced brain damage in a mouse model of Alzheimer’s.
  • Given the complexity of Alzheimer’s and the high cost and time required for new therapies, researchers turned to repurposing existing medications.
  • Using computational and experimental tests, the scientists screened over 1,300 FDA-approved drugs, finding ten that reversed Alzheimer’s gene signatures, and the combination therapy undid disease-related gene expression in neurons and glia while reducing toxic clumps and degeneration.
  • Dr. Huang said it's `so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model`, noting that the multi-target strategy may outperform current treatments but requires human trials.
  • Looking ahead, researchers plan to conduct clinical trials to assess the combination’s safety and efficacy in Alzheimer’s patients, given translation challenges from mice to humans.
Insights by Ground AI
Does this summary seem wrong?

34 Articles

KAKE NewsKAKE News
+22 Reposted by 22 other sources
Center

Study finds a combination of cancer drugs could treat Alzheimer’s

Scientists have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s disease.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

UC San Francisco broke the news in on Monday, July 21, 2025.
Sources are mostly out of (0)